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The crystal structure of Escherichia coli ketopantoate reduc-
tase in complex with 20-monophosphoadenosine 50-diphospho-
ribose, a fragment of NADP
+ that lacks the nicotinamide ring,
is reported. The ligand is bound at the enzyme active site in
the opposite orientation to that observed for NADP
+, with the
adenine ring occupying the lipophilic nicotinamide pocket.
Isothermal titration calorimetry with R31A and N98A
mutants of the enzyme is used to show that the unusual
‘reversed binding mode’ observed in the crystal is triggered by
changes in the protonation of binding groups at low pH. This
research has important implications for fragment-based
approaches to drug design, namely that the crystallization
conditions and the chemical modiﬁcation of ligands can have
unexpected effects on the binding modes.
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1. Introduction
Ketopantoate reductase (KPR; EC 1.1.1.169), an enzyme
involved in the biosynthesis of pantothenate (vitamin B5),
catalyses the reduction of ketopantoate to form pantoate
using NADPH as a cofactor (Ciulli & Abell, 2005). The
enzyme from Escherichia coli, encoded by the panE gene, has
been puriﬁed and extensively characterized both biochemi-
cally (Zheng & Blanchard, 2000a,b, 2003) and structurally
(Matak-Vinkovic et al., 2001; Lobley et al., 2005). The crystal
structure of the apoenzyme was solved at 1.70 A ˚ resolution
using the selenomethionine MAD method (Matak-Vinkovic et
al., 2001). KPR belongs to the 6-phosphogluconate dehydro-
genase superfamily in the SCOP database (Murzin et al., 1995)
and has properties of both class A and class B secondary
alcohol dehydrogenases (Zheng & Blanchard, 2000a). The
secondary structure comprises 15  -helices and 11  -strands.
The enzyme is monomeric and has two domains separated by
the active-site cleft. The N-terminal domain has the   
Rossmann-type fold featured in many nucleotide-binding
proteins, with a glycine-rich region (
7GCGALG
12) for
nucleotide recognition, whilst the C-terminus is an  -helical
domain. We have also solved the crystal structure of KPR in
complex with NADP
+ (Lobley et al., 2005). This structure
showed the cofactor bound in an extended conformation in
the cleft between the two domains and identiﬁed the inter-
actions formed with key residues at the enzyme active site
(Lobley et al., 2005). More recently, a systematic biophysical
analysis was conducted to probe hot spots at the cofactor-
binding site using a series of NADP
+ fragments and analogues
(Ciulli et al., 2006). There is a conservation of the NADP-like
binding mode across the series of fragments. The 20-phosphate
and the reduced nicotinamide are key binding groups for
cofactor recognition (Ciulli et al., 2006).In this paper, we report the three-dimensional structure of
KPR in complex with 20-monophosphoadenosine 50-diphos-
phoribose (20P-ADP-ribose), a fragment of NADPH that
lacks the nicotinamide ring, solved to 1.95 A ˚ resolution. The
structure surprisingly reveals the ligand to be bound in the
opposite orientation to that observed for NADP
+, with the
adenine ring occupying the lipophilic nicotinamide pocket.
Detailed analysis of this unexpected crystallographic result
using isothermal titration calorimetry (ITC) and site-directed
mutagenesis revealed that this unusual ‘reversed binding
mode’ is triggered by changes in the protonation of binding
groups at low pH.
2. Experimental
2.1. Protein expression, purification and site-directed
mutagenesis
For ITC studies, wild-type (WT) KPR and site-directed
mutants of KPR were expressed with an N-terminal His6 tag,
whereas WT KPR for crystallization studies had no tag. Both
constructs were expressed and puriﬁed as described previously
(Lobley et al., 2005; Ciulli et al., 2006). Puriﬁed His6-tagged
protein was dialyzed into the appropriate buffer using Slide-
A-Lyzer dialysis cassettes (Pierce). The protein concentration
was determined from the A280, using an absorption coefﬁcient
for His6-KPR of 62 650 M
 1 cm
 1 determined from amino-
acid analysis [Protein and Nucleic Acid Chemistry Facility
(PNAC), Cambridge]. An absorption coefﬁcient of
47 870 M
 1 cm
 1 estimated from the sequence was used for
untagged KPR. The genes for the singly mutated forms of
KPR, R31A and N98A were made using the QuickChange
Site-Directed Mutagenesis Kit (Stratagene) as described
previously (Ciulli et al., 2006).
2.2. Crystallization of KPR
Crystallization trials were carried out using the hanging-
drop vapour-diffusion method as described previously (Lobley
et al., 2005). Prior to crystallization, KPR samples (10–
15 mg ml
 1) were incubated at 277 K with NADPH and
pantoate at a ﬁnal ligand:protein ratio of 2:1 and 5:1, respec-
tively. Needle-like crystals of KPR were obtained in 10%
2-methyl-2,4-pentanediol (MPD) buffered with 0.1 M sodium
acetate pH 4.0–5.0. Crystals were cryoprotected in 30% MPD
buffered with 0.1 M sodium acetate at the same pH as the well
solution. Attempts to crystallize KPR at a pH close to 7 were
unsuccessful.
2.3. X-ray data collection, crystal structure determination
and refinement
X-ray data were collected to 1.95 A ˚ resolution at station
14.4, European Synchrotron Radiation Facility. The principal
parameters and data statistics for this data collection are
shown in Table 1. DENZO and SCALEPACK from the HKL-
2000 suite were used to process and scale the data (Otwi-
nowski & Minor, 1997). The structure was solved using
molecular replacement, with apo KPR as the probe structure.
AMoRe from the CCP4 suite (Collaborative Computational
Project, Number 4, 1994; Navaza, 1994, 2001) was used for
molecular replacement. After molecular replacement, the
initial model underwent simulated annealing using CNS
(Bru ¨nger et al., 1998) and initial electron-density maps were
generated. Reﬁnement involved an iterative cycle of manual
rebuilding in XTALVIEW (McRee, 1999) and maximum-
likelihood reﬁnement using REFMAC5 from the CCP4 suite
(Murshudov et al., 1997; Collaborative Computational Project,
Number 4, 1994). The completed structure is of residues 1–292
of KPR in complex with one molecule of 20P-ADP-ribose.
Nonprotein molecules were obtained from the HIC-Up
database (Kleywegt & Jones, 1998) and reﬁnement libraries
were taken from the PRODRG server (Schu ¨ttelkopf & van
Aalten, 2004).
2.4. Stability analysis of NADP(H)
The stability of NADPH and NADP
+ were investigated at
pH 5. 1.5 mg NADPH and 1.5 mg NADP
+ were dissolved in
700 ml0 . 1 M sodium acetate pH 5. NMR spectra were
recorded at 0, 2, 4, 24 and 48 h time intervals at 298 K on a
Bruker DRX 500 MHz spectrometer equipped with a 5 mm
triple-resonance inverse (TXI) cryoprobe with Z-gradients
using a presaturation pulse sequence. Mass spectrometry was
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Table 1
Statistics of KPR data collection and reﬁnement.
Values in parentheses are for the outer shell.
Data collection
X-ray source ESRF (14-4)
Space group P212121
Unit-cell parameters (A ˚ ,  ) a = 60.32, b = 65.83, c = 98.21,
  =   =   =9 0
Wavelength (A ˚ ) 0.939
Resolution range (A ˚ ) 50–1.95 (2.0–1.95)
No. of unique reﬂections 28985
Multiplicity 7.3
Rmerge 11.5 (47.6)
Average I/ (I) 23.2 (2.6)
Reﬂections with I/ (I) > 3 (%) 79.2 (10.6)
Completeness (%) 99.2 (92.7)
Mosaicity ( ) 0.70
Wilson B (A ˚ 2) 28.2
Reﬁnement
Rcryst† (%) 16.6
Rfree‡ (%) 19.4
No. of reﬂections in working set 27446
No. of reﬂections in test set 1471
No. of residues rebuilt 292
Model quality
Estimated coordinate error§ (A ˚ 2) 1.27
Ramachandran plot}
Most favoured (%) 98.6
Generously allowed (%) 1.4
Disallowed (%) 0
R.m.s.d. bonds (A ˚ ) 0.02
R.m.s.d. angles ( )1 . 8
Overall mean B (A ˚ 2) 31.1
† Rcryst =
P   jFobsj j Fcalcj
   =
P
jFobsj, where Fobs and Fcalc are the observed and
calculated structure-factor amplitudes. ‡ Rfree as for Rcryst using a random subset of
data excluded from the reﬁnement. § Estimated coordinate error based on the free R
value as calculated by REFMAC (Collaborative Computational Project, Number 4, 1994;
Murshudov et al., 1997). } Calculated using RAMPAGE (Lovell et al., 2003).carried out using a Micromass Quadrupole–Time of Flight
(Q-TOF) spectrometer. The degradation product of NADPH
was identiﬁed by mass spectrometry to be 20P-ADP-ribose:
m/z (C15H25 nN5NanO17P3) = 727.96 (n =4 ,M H
+, 90%),
705.98 (n = 3, 100%), 684.00 (n = 2, 45%).
2.5. Isothermal titration calorimetry
ITC experiments were performed on an OMEGA
isothermal titration calorimeter from Microcal Inc. at 300 K.
Puriﬁed protein was exhaustively dialyzed with 0.1 M HEPES
pH 7.7 and loaded into the sample cell at a ﬁnal concentration
of 30–80 mM. Sufﬁcient ligand was used to obtain at least 80%
saturation of the enzyme at the end of the titration, as esti-
mated using the equation given by Turnbull & Daranas (2003).
Typically, 35 injections of 7–8 ml were made at 3–4 min inter-
vals from a 300 ml syringe rotating at 300 rev min
 1. Alter-
natively, the initial 15 injections were of 3–4 ml and the ﬁnal 30
injections were of 7–8 ml, all at 3–4 min intervals. The heat
change accompanying the titration was recorded as differ-
ential power by the instrument and determined by integration
of the peak obtained. Titrations of ligands to buffer only were
performed to allow baseline corrections. The corrected heat
change was then ﬁtted using nonlinear least-squares mini-
mization to obtain the dissociation constants Kd, the enthalpy
of binding H and the stoichiometry n (Wiseman et al., 1989).
A stoichiometry of 1, determined from titrations with NADP
+
under a high c value, was ﬁxed during curve ﬁtting of data
obtained with 20P-ADP-ribose under low c-value conditions
(Ciulli et al., 2006). At least two experiments were performed
at different ligand concentrations to exclude the occurrence of
any concentration-dependent phenomena.
3. Results and discussion
3.1. Crystallization, structure solution and refinement
In an attempt to crystallize the ternary complex between
KPR, NADPH and pantoate, we explored conditions similar
to those used for the KPR–NADP
+ crystals (Lobley et al.,
2005) and obtained crystals at pH 4.0–5.0. Molecular
replacement using AMoRe (Collaborative Computational
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Figure 1
Crystal structure of the KPR–20P-ADP-ribose binary complex and comparison with the KPR–NADP
+ complex. (a)2 0P-ADP-ribose electron density.
The ﬁnal 2Fo   Fc electron-density map for 20P-ADP-ribose contoured at 1  is shown in blue. Binding modes of (b)2 0P-ADP-ribose and (c) NADP
+ and
the key residues at the active site of KPR are shown. The van der Waals surface of the N-terminal domain (residues 1–176) only is shown, coloured by
electrostatic potential (neutral, white; positive, blue; negative, red). (d) Superposition of the KPR–NADP
+ (salmon pink) and KPR–20P-ADP-ribose
(yellow) structures. The protein structures were superposed using the backbone atoms of residues 2–291.Project, Number 4, 1994; Navaza, 1994, 2001) with apo KPR
(Matak-Vinkovic et al., 2001) as the probe structure gave a
solution with an Rcryst of 21.2% and a correlation coefﬁcient of
55.7%. Initial 2Fo   Fc and Fo   Fc electron-density maps
clearly showed the presence of a nonprotein molecule in the
active site. However, no electron density corresponding to
pantoate was identiﬁed; instead, it was possible to ﬁt the
density corresponding to part of NADPH. Ultimately, one
molecule of 20P-ADP-ribose was built into this density (Fig.
1a). Although electron density is incomplete for the terminal
ribose, the presence of ﬁnal 2Fo   Fc electron density at 3–5 
around the phosphate groups gave a clear indication of the
position of the ligand and enabled its unambiguous modelling.
Maximum-likelihood reﬁnement implemented in REFMAC5
(Murshudov et al., 1997) was used to improve the quality of the
electron-density maps and facilitate further rebuilding and
improvement of the molecular model until no unexplained
electron density remained and the Rcryst and Rfree values
converged at 16.6 and 19.4%, respectively (Table 1). As in the
apo (Matak-Vinkovic et al., 2001) and holo (Lobley et al.,
2005) structures, the C-terminal residues were disordered and
nine residues were not rebuilt.
3.2. Identification of 2000P-ADP-ribose as the degradation
product of NADPH
The most likely source of 20P-ADP-ribose in the structure
was as a result of degradation of the NADPH used in the
cocrystallization experiments. NADPH is known to be an
inherently unstable compound (Burton & Kaplan, 1963;
Lowry et al., 1961). The hydrolysis of NADPH to 20P-ADP-
ribose has previously been observed in crystals of aceto-
hydroxyacid isomeroreductase grown in the presence of
NADPH (Thomazeau et al., 2000).
We monitored the stability of NADPH and NADP
+ at pH 5
using NMR spectroscopy to conﬁrm the degradation of
NADPH to 20P-ADP-ribose under the crystallization condi-
tions. Several NMR spectra were acquired over 48 h. At pH 5,
NADPH degraded completely within 4 h, whereas NADP
+ did
not show any degradation. The degradation of NADPH could
be monitored by following the disappearance of the reso-
nances at   2.7 (2H, H4, nicotinamide ring),   6.0 (1H, H6,
nicotinamide ring) and   7.0 (1H, H2, nicotinamide ring). The
disappearance of these peaks corresponded to the appearance
of a doublet at   5.5, which is indicative of the formation of
20P-ADP-ribose.
Mass-spectrometry experiments were used to conﬁrm the
formation of 20P-ADP-ribose upon incubation of NADPH at
pH 5. The peak observed at 728 Da corresponds to the
calculated weight of the protonated 20P-ADP-ribose tetra-
sodium salt. These measurements conﬁrmed the hydrolysis of
NADPH to 20P-ADP-ribose.
3.3. The structure of the binary complex of KPR with
2000P-ADP-ribose
20P-ADP-ribose binds to KPR in the active-site cleft
between the N-terminal Rossmann-fold domain and the
C-terminal  -helical domain. The adenine ring of 20P-ADP-
ribose hydrogen bonds to the main-chain amide and carboxyl
of Thr118, the 20-phosphate makes hydrogen bonds to Glu256
and Ser244, Asn98 binds the ribose O2 and O3 atoms and
provides part of the adenine pocket, the remaining part being
formed by the hydrophobic side chains of Leu11 and Ile96,
and the pyrophosphate makes hydrogen bonds with backbone
amide NH groups of Ala10 and Leu11 and with a structurally
conserved water molecule at the
7GCGALG
12 glycine-rich
loop (Bottoms et al., 2002). There is relatively poor electron
density in the region corresponding to the terminal ribose (see
Fig. 1a), suggesting that the binding of the ribose moiety may
be disordered.
The adenine recognition in the structure presented here can
be related to the adenine-binding motif described by Denes-
siouk et al. (2001). In this recognition motif, which is common
to many enzymes that bind adenine cofactors, an amino acid
forms hydrogen bonds to the N1 nitrogen and the NH2 group
of adenine with its backbone amide NH and carbonyl groups,
respectively. Here this residue is Thr118, which forms two
hydrogen bonds of 3.2 and 2.6 A ˚ , respectively. The hydro-
phobic side chains of Leu11 and Ile96 are positioned below
the plane of the adenine ring, which is another common
feature of the adenine-recognition motif.
3.4. Comparison with the KPR–NADP
+ binary complex
structure
A comparison of the KPR–NADP
+ and KPR–20P-ADP-
ribose structures is shown in Figs. 1(b), 1(c) and 1(d). Previous
biophysical studies identiﬁed the adenosyl-20-phosphate
pocket and the nicotinamide pocket for NADPH as two
distinct hot spots for ligand binding (Ciulli et al., 2006). In the
KPR–NADP
+ binary structure, both pockets are occupied by
the cofactor molecule (Fig. 1c). However, in the KPR–
20P-ADP-ribose binary structure only one pocket is occupied.
Here, the adenine group of 20P-ADP-ribose occupies the
apolar nicotinamide pocket (Fig. 1b), whilst no electron
density was found for binding in the adenosyl-20-phosphate
pocket. The ligand is consequently bound in the opposite
orientation to NADP
+ and we henceforth refer to this as the
‘reversed binding mode’. Closer inspection shows that many of
the interacting residues, e.g. Lys72, Asn98 and Glu256, are
common to both modes of binding (Figs. 1b and 1c). Super-
position of the two crystal structures reveals that the adenine
ring of 20P-ADP-ribose is almost coplanar with the nicotin-
amide ring of NADP
+ and the pyrophosphate groups from
each structure overlap well (Fig. 1d).
There are two notable differences in the active-site cleft of
KPR–20P-ADP-ribose when compared with KPR–NADP
+.
Firstly, the side chain of Arg31 moves towards Trp74 and
Gln75 in order to close the gap left by the absence of cofactor
in the adenine-binding pocket. Secondly, the side chain of
Lys176 points in the direction of the adenine ring (Fig. 1b)
rather than being involved in a hydrogen bond to Thr117 as in
the KPR–NADP
+ complex. Interestingly, in the KPR–20P-
ADP-ribose structure Lys176 adopts the conformation
research papers
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ketopantoate ternary complex model (Lobley et al., 2005).
3.5. Comparison with acetohydroxyacid isomeroreductase
crystal structures
Acetohydroxyacid isomeroreductase (AHIR; EC 1.1.1.86)
catalyses the conversion of acetohydroxy acid into dihydroxy-
valerate using NADPH as cofactor, which is the second step in
the biosynthetic pathway to the branched side-chain amino
acids valine, leucine and isoleucine (Biou et al., 1997). It is
known that AHIR can catalyze the same reaction as KPR
(Primerano & Burns, 1983; Matak-Vinkovic et al., 2001). In a
recently published crystal structure of AHIR (PDB code
1qmg), crystallization was carried out in the presence of
NADPH and the substrate 2-aceto-2-hydroxybutyrate at pH
7.2 (Thomazeau et al., 2000). Instead of NADPH, 20P-ADP-
ribose was bound in the active site, which was also shown to be
a result of cofactor degradation (Thomazeau et al., 2000).
However, in this structure 20P-ADP-ribose was bound in the
same conformation as NADPH, as had been previously seen
in the crystal structure of the AHIR–NADPH complex (PDB
code1yve;Biouetal.,1997),whichwasalsoobtainedatpH7.2.
The observation of the two different binding orientations
for 20P-ADP-ribose in AHIR and KPR was unexpected.
However, the conditions under which the two proteins were
crystallized were not identical and speciﬁcally the pH was
quite different. The crystallization conditions for KPR were at
a pH between 4.0 and 5.0, whereas those for AHIR were at pH
7.2. Furthermore, recent biophysical studies of KPR with
cofactor fragments have shown that 20P-ADP-ribose adopts
the same binding mode as NADP
+ at physiological pH (Ciulli
et al., 2006). Therefore, it was considered possible that the
difference in pH was giving rise to the reversed binding mode
observed in the KPR complex. There is precedent for protein
crystallization conditions, particularly pH, having a pro-
nounced effect on the binding mode of a ligand (Davis et al.,
2003). To resolve this issue, the binding interaction of KPR
research papers
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Figure 2
ITC analysis of 20P-ADP-ribose binding to KPR at different pH values. ITC experiments are shown for His6-KPR titrated with 20P-ADP-ribose at 300 K
in (a)0 . 1M HEPES–HCl pH 7.7 and (b)9 0m M sodium acetate, 5 mM HEPES pH 4.5. Top panels: raw data for titrations of 1–2 mM ligand into 30–
60 mM protein. Each peak corresponds to one injection. An initial 1 ml injection was followed by 35   8 ml( a)o r2 8  10 ml injections (b). Bottom panel:
integration of the data, corrected for the heat of dilution. The line represents the least-squares ﬁt to the single-site binding model by the Origin program.with NADP
+ and 20P-ADP-ribose were investigated under
different pH conditions using ITC.
3.6. Isothermal titration calorimetry
ITC studies have been previously conducted with substrates
(Lobley et al.,2005), cofactors and cofactor analogues (Ciulli et
al., 2006; Ciulli & Abell, 2005) binding to KPR at pH 7.7.
Titrations of His6-KPR with 20P-ADP-ribose were repeated at
pH 4.5 under conditions similar to those of crystallization.
Typical ITC traces are shown in Fig. 2. Similar experiments
were also conducted with NADP
+ as reference. The thermo-
dynamic parameters of the interactions were characterized
(Table 2) and compared with those determined at pH 7.7. The
dissociation constant of NADP
+ at pH 4.5 was 100 mM,a n
increase of 17-fold relative to pH 7.7 (Table 2). In contrast,
20P-ADP-ribose was found to bind only four times more
weakly at pH 4.5 (Kd = 250 mM) than at pH 7.7. Moreover, the
relative enthalpic and entropic contri-
butions to afﬁnity changed signiﬁcantly
in the case of the fragment, with a
large negative H of  51.1 kJ mol
 1
at pH 4.5 compared with a H of
 12.6 kJ mol
 1 observed at pH 7.7.
Large changes in H often indicate
a change in binding mode (Ward &
Holdgate, 2001; Holdgate & Ward,
2005).
3.7. Calorimetric analysis of the effect
of R31A and N98A mutations
ITC binding studies suggested a
change in the binding mode of 20P-
ADP-ribose with pH. To provide
additional structural evidence for the
proposed changes, single point muta-
tions of Arg31 and Asn98 to Ala were
constructed. Mutants R31A and N98A
of His6-KPR had been previously used
to probe fragment binding and locate
the site of interaction (Ciulli et al.,
2006).
Titrations of 20P-ADP-ribose and
NADP
+ against the R31A and N98A
mutants of KPR were conducted at pH
4.5 using ITC under the same conditions
used for the WT enzyme and were
compared with those obtained at pH 7.7
(Ciulli et al., 2006). Thermodynamic
data for the KPR mutants relative to
WT are reported in Table 3 as G
(Gmutant   GWT) together with
the relative contributions from H
(Hmutant   HWT) and  TS
[ T(Smutant   SWT)]. At pH 7.7, the
effects of both mutations on 20P-ADP-
ribose binding are consistent with those
on NADP
+ binding, suggesting that the fragment adopts the
same binding mode of NADP
+. In particular, the side chain of
Arg31 appears to be crucial for ligand recognition by binding
research papers
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Figure 3
Changes in protonation states tune the binding mode of 20P-ADP-ribose. (a) At pH 7.7 both the 20-
phosphate group of the ligand and Glu256 will be negatively charged, carrying a  2 and a  1
charge, respectively. Their interaction would be highly unfavourable. The ligand binds in the same
orientation observed for NADP
+, anchoring the 20-phosphate close to Arg31 and hydrogen bonding
to Glu256 via the terminal ribose. (b) Binding mode observed in the KPR–20P-ADP-ribose crystal
structure reported here. At pH 4.5 the 20-phosphate becomes protonated (pK = 6.5) carrying a
single negative charge. Glu256 is likely to protonate, allowing a favourable hydrogen bond to the 20-
phosphate group.
Table 2
Thermodynamic parameters of nucleotide binding to E. coli KPR.
Errors quoted are standard deviations from multiple experiments.
Ligand
Kd
(mM)
G
(kJ mol
 1)
H
(kJ mol
 1)
 TS
(kJ mol
 1)
pH 7.7†
NADP
+ 5.8   0.8  30.2   0.3  13.4   0.4  17.2   0.4
20P-ADP-ribose 61   8  24.3   0.3  12.6   1.3  11.7   1.7
pH 4.5‡
NADP
+ 100   4  23.1   0.1  7.1   2.1  16.0   2.1
20P-ADP-ribose 250   65  20.8   0.7  51.1   3.8 30.1   4.6
† From Ciulli et al. (2006). ITC titrations were performed in 0.1 M HEPES–HCl pH 7.7
at 300 K. ‡ ITC titrations were performed in 90 mM sodium acetate, 5 mM HEPES–
HCl pH 4.5 at 300 K.with the 20-phosphate group (Ciulli et al., 2006). In contrast,
the results at pH 4.5 for 20P-ADP-ribose binding differ from
those of NADP
+ under the same conditions, which is consis-
tent with the change of binding mode observed in the crystal
structure relative to the cofactor. At pH 4.5, the Arg to Ala
mutation does not affect the afﬁnity of 20P-ADP-ribose (G
< 0.4 kJ mol
 1; Table 3) and thus no longer discriminates
against binding the ligand. These results suggest that Arg31 is
not involved in the recognition of 20P-ADP-ribose at pH 4.5.
In the reversed binding mode found in the crystal this side
chain is at a distance of more than 8 A ˚ from the ligand.
Although there are changes in H and TS of 8.0 kJ mol
 1
for this interaction on mutation of Arg31, these changes are
compensatory and can be explained as being a consequence of
a change in protein structure or dynamics, rather than
evidence of a direct interaction with Arg31. Conversely, the
N98A mutation affected the thermodynamic parameters of
20P-ADP-ribose binding at pH 4.5 (Table 3) in a manner that is
consistent with the side chain interacting with the adenosyl
group of the ligand. There were large changes in H and
 TS, although these were compensatory and thus resulted
in only a small change in G. More importantly, these
changes were remarkably different from those observed with
NADP
+ at the same pH, further supporting the change in
binding mode.
3.8. Effect of pH: rationalization of the reversed binding
mode
We interpret these data as showing that the binding mode of
20P-ADP-ribose is reversed at pH 4.5, presumably as a con-
sequence of changes in protonation states (Fig. 3). The second
pK of the 20-phosphate group will be around 6.4 (Mas &
Colman, 1984). At pH 7.7 the 20-phosphate will be doubly
charged and will interact strongly with Arg31, whereas inter-
action with the carboxylate side chain of Glu256, which is also
negatively charged, would be unfavourable (Fig. 3a). In
contrast, at pH 4.5 the 20-phosphate would be present as the
monoanion and Glu256 will be partially protonated. Inter-
action with the 20-phosphate of the ligand will then be more
favourable (Fig. 3b) and is observed in the crystal structure at
a hydrogen-bonding distance of 2.4 A ˚ .
These changes in protonation states
have triggered an otherwise unfavour-
able contact between a carboxylate and
phosphate group and contributed
signiﬁcantly to the reversed binding
mode observed in the crystal.
4. Conclusions
In a combined crystallographic, calori-
metric and mutagenic approach, we
have shown how changes in pH tune the
binding of a ligand, leading to two
distinct binding modes of 20P-ADP-
ribose. The crystal structure of the
KPR–20P-ADP-ribose complex is to our knowledge the ﬁrst
example of a reversed binding mode at the active site of a
dehydrogenase. Such a novel binding mode may be possible
for homologous enzymes from the same family. In the case of
AHIR, a side-chain carboxylate (Asp202) binds the ribose
hydroxyl groups of the cofactor in a similar way as Glu256 in
KPR and could accommodate the reversed binding mode at
low pH.
Targeting the cofactor-binding site of dehydrogenases such
as KPR is a potential drug-design strategy for the develop-
ment of novel antimicrobial compounds. This result serves as a
cautionary tale for rational design using fragment-based
approaches, where structural information, primarily from
X-ray crystallography, is used for lead optimization. Further-
more, it stresses the importance of using complementary
solution techniques such as ITC to supplement crystallo-
graphy. High-resolution crystal structures of protein–ligand
complexes remain the ‘gold standard’ for structure-based drug
discovery, but due regard must be given to the conditions
under which they are determined.
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